Search

According to a large retrospective study co-led by Memorial Sloan Kettering Cancer Center and published in the Journal of Clinical Oncology, PTCy is an acceptable alternative to CNI-based prophylaxis in MUD HCT recipients and superior for MMUD HCT. These results will help improve minority donor participation in the NMDP registry.

… Wednesday, July 17, 2024 Post-transplantation cyclophosphamide (PTCy) led to similar overall survival (OS) and graft-versus-host disease (GVHD)-free relapse-free survival (GRFS) in patients who received a hematopoietic stem cell transplant (HCT) from a matched unrelated donor (MUD) and those who received

In a recent interview, MSK's Dr. Jeffrey Drebin addressed why it’s important for people to keep up with their routine screenings and not put off cancer treatment or surgery.

… Wednesday, July 15, 2020 Cancer care is essential care and screenings and treatments can’t wait. That was the message that MSK’s Chair of the Department of Surgery, Jeffrey Drebin, MD, PhD , shared during a recent interview with Spectrum News NY1 .  Appearing via Skype with Roma Torre on the New York

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that two Sloan Kettering Institute (SKI) researchers have been named 2022 Marie-Josée Kravis WISE fellowship grant recipients.

… Wednesday, March 23, 2022 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that two Sloan Kettering Institute (SKI) researchers have been named 2022 Marie-Josée Kravis (WISE) fellowship grant recipients. The Kravis WISE Symposium is held every year during Women’s History Month in March

As long-term cancer survival outcomes improve, the brain has increasingly become a site of refractory and recurrent disease.

… Thursday, May 22, 2025 As long-term cancer survival outcomes improve, the brain has increasingly become a site of refractory and recurrent disease. At Memorial Sloan Kettering Cancer Center (MSK),  neurosurgeon Nelson Moss, MD , Co-Director of the  Multidisciplinary Brain Metastasis Program , and  radiation

Sloan Kettering Institute investigators are taking important steps toward being able to identify all the cell types in tumors. With this information, they can figure out how the cells work together.

… Thursday, June 28, 2018 Summary Sloan Kettering Institute investigators are laying the groundwork for research into the different cell types in found in and around tumors. The composition of malignant tumors is incredibly complex. They contain not only cancer cells but also dozens of other cell types

Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is widely recognized as someone who is revolutionizing the molecular treatment of cancer.

… Saturday, December 8, 2012 Summary Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is widely recognized as someone who is revolutionizing the molecular treatment of cancer. President Barack Obama announced on December 6 his intent to appoint Memorial Sloan

Memorial Sloan Kettering Cancer Center (MSK) and Lehigh Valley Health Network (LVHN) announced today the beginning of a unique and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and highest-caliber cancer care.

… Tuesday, August 4, 2015 Memorial Sloan Kettering Cancer Center (MSK) and Lehigh Valley Health Network (LVHN) announced today the beginning of a unique and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and highest-caliber cancer

Dana Pe’er, PhD, computational biologist and lab head at Memorial Sloan Kettering Cancer Center’s (MSK) Sloan Kettering Institute (SKI), is one of 33 biomedical researchers named a Howard Hughes Medical Institute (HHMI) investigator today.

… Thursday, September 23, 2021 Dana Pe’er, PhD , computational biologist and lab head at Memorial Sloan Kettering Cancer Center’s (MSK) Sloan Kettering Institute (SKI), is one of 33 biomedical researchers named a Howard Hughes Medical Institute (HHMI) investigator today. The elite group of scientists,

An enzyme that contributes to plaque formation in the brain also serves as a first line of defense against bacteria and viruses, suggesting a link between the two.

… Wednesday, September 2, 2020 Summary Scientists at the Sloan Kettering Institute have discovered a direct link between the immune response to viruses and bacteria and the development of plaques in the brain that characterize Alzheimer’s disease. Alzheimer’s disease is a neurodegenerative condition that

Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it.

… Friday, July 11, 2014 Summary Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it. The word “transformation” perfectly characterizes and captures the past year at Memorial Sloan Kettering. Indeed, it’s the word we